Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-29 4:32 pm Purchase |
2024-10-25 | 13D | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 9,888,592 24.500% |
1,192,387 (+13.71%) |
Filing History |
| 2023-11-20 5:07 pm Purchase |
2023-11-17 | 13D | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 8,696,205 23.900% |
2,203,688 (+33.94%) |
Filing History |
| 2023-11-07 4:41 pm Purchase |
2023-11-03 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 6,492,517 17.900% |
1,982,445 (+43.96%) |
Filing History |
| 2023-02-14 12:10 pm Sale |
2022-12-31 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 4,510,072 12.600% |
-16,210 (-0.36%) |
Filing History |
| 2022-01-12 5:05 pm Purchase |
2022-01-10 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 4,526,282 14.100% |
1,425,000 (+45.95%) |
Filing History |
| 2022-01-12 5:03 pm Purchase |
2021-12-31 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 3,101,282 9.700% |
602,381 (+24.11%) |
Filing History |
| 2021-09-15 5:17 pm Purchase |
2021-08-16 | 13G | Molecular Partners AG MOLN |
BIOTECHNOLOGY VALUE FUND L P | 2,498,901 7.700% |
2,498,901 (New Position) |
Filing History |